GFACX
Price
$62.05
Change
+$0.45 (+0.73%)
Updated
May 8 closing price
Net Assets
283.8B
VIGRX
Price
$199.65
Change
+$1.55 (+0.78%)
Updated
May 8 closing price
Net Assets
269.26B
Ad is loading...

GFACX vs VIGRX

Header iconGFACX vs VIGRX Comparison
Open Charts GFACX vs VIGRXBanner chart's image
American Funds Growth Fund of Amer C
Price$62.05
Change+$0.45 (+0.73%)
VolumeN/A
Net Assets283.8B
Vanguard Growth Index Investor
Price$199.65
Change+$1.55 (+0.78%)
VolumeN/A
Net Assets269.26B
GFACX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. VIGRX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and VIGRX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 284B vs. VIGRX (269B). VIGRX pays higher dividends than GFACX: VIGRX (0.38) vs GFACX (0.00). GFACX was incepted earlier than VIGRX: GFACX (24 years) vs VIGRX (33 years). GFACX (1.36) is less costly to investors than VIGRX (0.17). GFACX is a more actively managed with annual turnover of: 25.00 vs. VIGRX (11.00). GFACX has a lower initial minimum investment than VIGRX: GFACX (250) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 11.75 vs. GFACX (0.67). VIGRX return over 5 years is better than : 107.33 vs. GFACX (33.68).
GFACXVIGRXGFACX / VIGRX
Total Expense Ratio1.360.17800%
Annual Report Gross Expense Ratio1.360.17800%
Fund Existence24 years33 years-
Gain YTD-3.388-6.50852%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets284B269B106%
Annual Yield % from dividends0.000.38-
Returns for 1 year0.6711.756%
Returns for 3 years21.0256.4237%
Returns for 5 years33.68107.3331%
Returns for 10 years43.52252.9017%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX121.612.69
+2.26%
Neurocrine Biosciences
VMEO4.680.04
+0.75%
Vimeo
INDP0.43N/A
N/A
Indaptus Therapeutics
IART12.73-0.02
-0.16%
Integra LifeSciences Holdings Corp
SLN3.70-0.05
-1.33%
Silence Therapeutics Plc